All In Biotech

Drug Trial Radar · NCT06680037

A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

A Phase 1, Open-label Study to Evaluate the Safety and Clinical Activity of Azercabtagene Zapreleucel in Participants With B-cell Mediated Autoimmune Disorders

Last checked: Nov 20, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

May 6, 2025

Primary completion

Dec 1, 2026

Study completion Jan 1, 2029

Sponsor

Lead sponsor
TG Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Nov 8, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main objective of the study is to determine the recommended phase 2 dose (RP2D) of Azercabtagene zapreleucel (azer-cel).

Conditions

  • B-cell Mediated Autoimmune Disorders

Interventions

  • Azercabtagene zapreleucel (azer-cel)Drug

    IV infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants with Dose-Limiting Toxicities (DLTs)Time frame: From Day 0 to Day 28

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • TG Therapeutics Investigational Trial Site

    La Jolla, California · Recruiting

  • TG Therapeutics Investigational Trial Site

    Ann Arbor, Michigan · Recruiting

  • TG Therapeutics Investigational Trial Site

    Omaha, Nebraska · Recruiting

  • TG Therapeutics Investigational Trial Site

    New York, New York · Recruiting

  • TG Therapeutics Investigational Trial Site

    Rochester, New York · Recruiting

  • TG Therapeutics Investigational Trial Site

    Cleveland, Ohio · Recruiting

  • TG Therapeutics Investigational Trial Site

    Columbus, Ohio · Recruiting

  • TG Therapeutics Investigational Trial Site

    Milwaukee, Wisconsin · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.